
Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]
Loading…
Data from Twelve Data. Prices may be delayed.
No analyst coverage available.
Initial Jobless Claims
8:30 AM ET

Bitcoin (BTC)
75,256 +0.74%

Ethereum (ETH)
2,132 +0.38%

Solana (SOL)
87 +0.23%

Corporate PresentationNov 9, 2026
Faeth Therapeutics, Inc. (FTH) is a clinical-stage biotechnology company developing multi-node inhibitors for cancer treatment. Our focus is on improving patient outcomes by targeting critical oncogenic pathways. The lead program, PIKTOR, is an investigational all-oral combination therapy. It specifically targets the PI3K/AKT/mTOR pathway.
Generated by AI